Rating agency ICRA assigned `LA` rating to Rs 0.50 billion non convertible debenture (NCD) programme of SRL Ranbaxy (Q, N,C,F)* (SRL). Rating indicates adequate credit quality in the long term.
The rating factors in SRL`s strong parentage, its pan-India presence in diagnostic industry and high quality standards maintained in test results. Over the years, SRL has focused on reducing delivery time for test results and expanding its geographical coverage and reach, which has led to substantial improvement in its turnover and profitability and enabled it to wipe out its accumulated losses.
0 comments:
Post a Comment